NSE - SMEListed
Curis Lifesciences Limited
Company websiteCuris Lifesciences Limited seeks to raise ₹21,50,000 crore — fresh issue ₹21,50,000 crore, OFS ₹0 crore. Total shares offered: 1000.
Subscribe between 07-11-2025 and 11-11-2025. Allotment is expected on 12-11-2025, with listing on 14-11-2025. Action tip: if you’re unsure, consider starting with a small allocation and review the company’s prospectus.
Start Date07-11-2025
End Date11-11-2025
Listing Date14-11-2025
Allotment Date12-11-2025
Current Price₹146.10
GMP₹7 (5.47%)
Lot Size1000 Shares
Subscription74.47 Times
Face Value₹10 per share
Listing atNSE
Issue Price₹120 - ₹128
Pre Issue₹59,34,434
Post Issue₹80,84,434
Issue Size₹21,50,000
(aggregating up to 27.52 Cr)
(aggregating up to 27.52 Cr)
Fresh Issue₹21,50,000
(aggregating up to 27.52 Cr)
(aggregating up to 27.52 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Curis Lifesciences Limited is currently around ₹7 (5.47%). This indicates an estimated listing price of approximately ₹127 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
12 Nov 2025, 15:14 | ₹128 | ₹7 | ₹135 (5.47%) |
11 Nov 2025, 10:13 | ₹128 | ₹4 | ₹132 (3.13%) |
10 Nov 2025, 10:58 | ₹128 | ₹5 | ₹133 (3.91%) |
07 Nov 2025, 11:05 | ₹128 | ₹4 | ₹132 (3.13%) |
06 Nov 2025, 09:57 | ₹128 | ₹4 | ₹132 (3.13%) |
04 Nov 2025, 11:16 | ₹128 | ₹0 | ₹128 (0.00%) |
31 Oct 2025, 05:19 | ₹128 | ₹0 | ₹128 (0.00%) |
Financials overview In Crores
Here is a quick look at the recent financial performance of Curis Lifesciences Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Jul-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
EPS | 0 | 0 | 0 | 0 |
ROE | 16.26 | 55.25 | 141.51 | 2752.56 |
ROCE | 11.65 | 27.83 | 33.57 | 14.83 |
RONW | 0 | 0 | 0 | 0 |
PRE IPO(PE) | 0 | 12.44 | 0 | 0 |
POST IPO(PE) | 12.01 | 0 | 0 | 0 |
Subscription Details (No. of Shares)
The below shows how many shares were subscribed by each investor category in the Curis Lifesciences Limited IPO. These numbers help you understand where the demand is coming from – whether it’s retail investors, QIBs, or NIBs. Higher subscription usually indicates strong interest and confidence from the market.
Subscription Demand (in ₹ Crore)
| Category | Offered | Demand | Times |
|---|---|---|---|
QIBs | ₹5.24 | 503.49 | 96.09 |
FIIs | ₹0 | 187.28 | 0.00 |
FIs | ₹0 | 10.34 | 0.00 |
Others | ₹0 | 305.87 | 0.00 |
RETAIL | ₹9.16 | 405.84 | 44.31 |
NIB | ₹3.94 | 456.59 | 115.89 |
HNIs 2+ | ₹1.31 | 78.84 | 60.18 |
HNIs 10+ | ₹2.64 | 377.75 | 143.09 |
Total | ₹18.35 | 1365.92 | 74.44 |
Application Wise Breakup (Approx. no of Apps)
| Category | Reserved | Applied | Times |
|---|---|---|---|
QIB | 0 | 44 | 0.00 |
NIB | 0 | 5,576 | 0.00 |
RETAIL | 358 | 15,853 | 44.28 |
HNIs(10L +) | 69 | 3,605 | 52.25 |
HNIs (2-10L) | 34 | 1,971 | 57.97 |
Total | 461 | 21,429 | 46.48 |
The IPO reservation for Curis Lifesciences Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Anchor | 28.37% | 6,10,000 |
QIB | 18.98% | 4,08,000 |
HNI | 14.33% | 3,08,000 |
RETAIL | 33.30% | 7,16,000 |
Market Maker | 5.02% | 1,08,000 |
TOTAL | 100.00% | 21,50,000 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 2 | 2,000 | ₹2,56,000 | |
sHNI | 3 | 3,000 | ₹3,84,000 | |
bHNI | 8 | 8,000 | ₹10,24,000 |
Below you can find the official contact details of Curis Lifesciences Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: cs@curisls.com
Phone: +91 99045 22543
Website: https://curisls.com/
Address: PF-23, GIDC Sanand - II, Industrial Estate, Sanand Ahmedabad, Gujarat, 382110
IPO Registrar
Name: Link Intime India Private Limited
Phone: +91-22-4918 6270